X

Xenetic Biosciences
D

XBIO

4.30000
USD
0.38
(9.69%)
Market Closed
Volume
1,390
EPS
-2
Div Yield
-
P/E
-2
Market Cap
6,631,198
OverviewSignalsIdeasNews
Related Instruments
    A
    ALT
    -0.85500
    (-10.11%)
    7.60000 USD
    A
    AYTU
    -0.03000
    (-1.94%)
    1.52000 USD
    B
    BIOC
    -0.09610
    (-18.27%)
    0.42990 USD
    B
    BNGO
    -0.00920
    (-3.60%)
    0.24620 USD
    N
    NBRV
    0.04000
    (2.84%)
    1.45000 USD
    T
    TRVN
    -2.02000
    (-44.99%)
    2.47000 USD
    More
News

Title: Xenetic Biosciences

Sector: Healthcare
Industry: Biotechnology
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immune-oncology technologies addressing cancers. The company is also engaged in progressing XCART, a personalized CAR T platform technology. The Company's DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which have been implicated in cancer progression and resistance to cancer treatments. The company also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin-resistant endometrial cancer.